Adrian Adams is the founder of Impel NeuroPharma. Impel NeuroPharma has raised $250M in total funding. Latest round: IPO. Based in Seattle, USA.
Adrian Adams is the Chairman and CEO of Impel NeuroPharma, a late-stage biopharmaceutical company based in Seattle. The company focuses on developing and commercializing transformative therapies for patients with central nervous system (CNS) disorders. Adams previously served as Chairman of Impel NeuroPharma's Board of Directors starting in January 2020. He has extensive experience as a CEO of multiple public companies and in board governance for various public and private companies.
Full founder directory · Investor directory · Company funding database · Fundraising library